Skip to main content
. 2022 Jan 17;2022:3837418. doi: 10.1155/2022/3837418

Table 4.

Maintenance therapy over time: intensity of asthma treatment in both groups.

Placebo Active treatment
No therapy Low intensity Mild intensity High intensity No therapy Low intensity Mild intensity High intensity
T0  83 (40.5%) 40 (19.5%) 38 (18.5%) 44 (21.5%) 95 (45.5%) 36 (17.2%) 30 (14.4%) 48 (23.0%)
T1  86 (42.2%) 41 (20.1%) 37 (18.1%) 40 (19.6%) 95 (46.6%) 33 (16.2%) 28 (13.7%) 48 (23.5%)
T2  99 (49.0%) 35 (17.3%) 29 (14.4%) 39 (19.3%) 98 (48.3%) 33 (16.3%) 31 (15.3%) 41 (20.2%)
T3  103 (51.5%) 33 (16.5%) 27 (13.5%) 37 (18.5%) 104 (51.7%) 38 (18.9%) 29 (14.4%) 30 (14.9%)
T4  123 (61.8%) 23 (11.6%) 25 (12.6%) 28 (14.1%) 115 (57.2%) 32 (15.9%) 24 (11.9%) 30 (14.9%)